The IP6K2 gene was linked to worse clinical progression, particularly higher depression levels in prodromal cases, and is known for its neuroprotective role in preventing PTEN-induced kinase 1 (PINK1)-mediated mitophagy in the brain [71]. This evidence concerns the gene IP6K2 and depressive symptom measurement.